A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor
Diabetes Technology & Therapeutics · 2024
DOI: 10.1089/dia.2024.0170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Technology & Therapeutics, 2024. Verfasst von Fazle Karim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Know Labs, Inc., Seattle, Washington, USA. Hauptthemen laut MEDLINE: Blood Glucose, Blood Glucose Self-Monitoring, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Know Labs, Inc., Seattle, Washington, USA.
- Department of Mathematics, Central Washington University, Ellensburg, Washington, USA.
- Mayo Clinic, Rochester, Minnesota, USA.
ORCID-Profile: Fazle Karim, Kaptain Currie, Dominic Klyve
Zitieren
APA
Karim, F., Anderson, J. H., Currie, K., Bui, C., Klyve, D., & Somers, V. K. (2024). A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor. Diabetes Technology & Therapeutics. https://doi.org/10.1089/dia.2024.0170
Vancouver
Karim F, Anderson JH, Currie K, Bui C, Klyve D, Somers VK. A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor. Diabetes Technology & Therapeutics. 2024. doi:10.1089/dia.2024.0170
BibTeX
@article{Karim2024,
author = {Karim, Fazle and Anderson, James H and Currie, Kaptain and Bui, Connor and Klyve, Dominic and Somers, Virend K},
title = {A Glycemic Status Classification Model Using a Radiofrequency Noninvasive Blood Glucose Monitor},
journal = {Diabetes Technology & Therapeutics},
year = {2024},
doi = {10.1089/dia.2024.0170}
}
EUVIMED